NO20083023L - Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur - Google Patents

Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur

Info

Publication number
NO20083023L
NO20083023L NO20083023A NO20083023A NO20083023L NO 20083023 L NO20083023 L NO 20083023L NO 20083023 A NO20083023 A NO 20083023A NO 20083023 A NO20083023 A NO 20083023A NO 20083023 L NO20083023 L NO 20083023L
Authority
NO
Norway
Prior art keywords
dendritic cells
lowered temperature
generating dendritic
generating
relates
Prior art date
Application number
NO20083023A
Other languages
English (en)
Norwegian (no)
Inventor
Alexei Kirkin
Karine Djandjougazian
Jesper Zeuthen
Original Assignee
Dandrit Biotech As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dandrit Biotech As filed Critical Dandrit Biotech As
Publication of NO20083023L publication Critical patent/NO20083023L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0639Dendritic cells, e.g. Langherhans cells in the epidermis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5154Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/22Colony stimulating factors (G-CSF, GM-CSF)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/25Tumour necrosing factors [TNF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20083023A 2005-12-08 2008-07-08 Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur NO20083023L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200501742 2005-12-08
PCT/DK2006/000694 WO2007065439A1 (en) 2005-12-08 2006-12-07 Method for generating dendritic cells employing decreased temperature

Publications (1)

Publication Number Publication Date
NO20083023L true NO20083023L (no) 2008-08-28

Family

ID=37745820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083023A NO20083023L (no) 2005-12-08 2008-07-08 Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur

Country Status (18)

Country Link
US (1) US9771558B2 (de)
EP (1) EP1971680B1 (de)
JP (1) JP2009518017A (de)
CN (1) CN101321861B (de)
AT (1) ATE545698T1 (de)
AU (1) AU2006322451A1 (de)
BR (1) BRPI0619520A2 (de)
CA (1) CA2640836C (de)
CY (1) CY1113016T1 (de)
DK (1) DK1971680T3 (de)
EA (1) EA015266B1 (de)
ES (1) ES2382565T3 (de)
IL (1) IL191782A (de)
MY (1) MY145814A (de)
NO (1) NO20083023L (de)
NZ (1) NZ569343A (de)
PT (1) PT1971680E (de)
WO (1) WO2007065439A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009062502A1 (en) * 2007-11-13 2009-05-22 Dandrit Biotech A/S Method for generating tolerogenic dendritic cells employing decreased temperature
RU2486238C1 (ru) * 2011-12-29 2013-06-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Сибирский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО СибГМУ Минздравсоцразвития России) СПОСОБ НАГРУЗКИ ДЕНДРИТНЫХ КЛЕТОК АНТИГЕНОМ ИНФЕКЦИОННОГО ПРОИСХОЖДЕНИЯ Opisthorchis felineus
RU2663468C1 (ru) * 2017-09-25 2018-08-06 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ лечения местно-распространенного нерезектабельного рака поджелудочной железы
AU2020414040A1 (en) * 2019-12-27 2022-08-18 Zeria Pharmaceutical Co., Ltd. Cancer treatment method and medicine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4306813B2 (ja) * 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
US5849589A (en) * 1996-03-11 1998-12-15 Duke University Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
US20050084966A1 (en) * 1999-04-20 2005-04-21 Edelson Richard L. Methods for inducing the differentiation of blood monocytes into functional dendritic cells
US20010026937A1 (en) * 2000-01-11 2001-10-04 Juha Punnonen Monocyte-derived dendritic cell subsets
CN1168740C (zh) * 2001-04-04 2004-09-29 上海美恩生物技术有限公司 细胞因子基因修饰的抗原提呈细胞/肿瘤细胞偶联物、其制法和用途
US20040009596A1 (en) * 2002-03-28 2004-01-15 Rao Kanury V. S. Extract from an Indian green mussel (perna viridis) for differentiation and maturation of dendric cells
JP4219789B2 (ja) 2002-10-30 2009-02-04 独立行政法人科学技術振興機構 骨髄由来の不死化樹状細胞株
WO2004092220A1 (en) 2003-04-14 2004-10-28 Board Of Regents, The University Of Texas System Methods for ex vivo hybridoma-free production of polyclonal and monoclonal antibodies and generation of immortalized cell populations
US20050003533A1 (en) * 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
EP1882031B1 (de) * 2005-04-08 2017-11-08 Argos Therapeutics, Inc. Dendritische zellzusammensetzungen und verfahren

Also Published As

Publication number Publication date
EA200801385A1 (ru) 2008-10-30
PT1971680E (pt) 2012-05-23
JP2009518017A (ja) 2009-05-07
CA2640836C (en) 2018-05-15
ATE545698T1 (de) 2012-03-15
CA2640836A1 (en) 2007-06-14
WO2007065439A1 (en) 2007-06-14
ES2382565T3 (es) 2012-06-11
AU2006322451A1 (en) 2007-06-14
MY145814A (en) 2012-04-30
CY1113016T1 (el) 2016-04-13
CN101321861B (zh) 2012-10-24
IL191782A0 (en) 2008-12-29
US20090196856A1 (en) 2009-08-06
EP1971680A1 (de) 2008-09-24
EP1971680B1 (de) 2012-02-15
EA015266B1 (ru) 2011-06-30
CN101321861A (zh) 2008-12-10
BRPI0619520A2 (pt) 2011-10-04
IL191782A (en) 2012-05-31
DK1971680T3 (da) 2012-06-11
NZ569343A (en) 2011-11-25
US9771558B2 (en) 2017-09-26

Similar Documents

Publication Publication Date Title
WO2009117344A3 (en) Non-hydroxide base and protein denaturant hair straightening composition and process
DE602005012233D1 (de) Ap2-domäne-transkriptionsfaktor odp2 (ovule development protein 2) und verwendungsverfahren
NO20076046L (no) Bindemidler
MY194500A (en) Methods and Compositions for Producing Fatty Alcohols
NZ584893A (en) PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
MX2021015070A (es) Inmunomodulacion usando celulas madre de la placenta.
DK1948789T3 (da) Fremgangsmåde til fremstilling af permanente, humane cellelinjer
EA200601822A1 (ru) Способы получения полиморфной формы i гидросульфата клопидогрела
EA200701656A1 (ru) Противообледенительная и/или антиобледенительная композиция и способ уменьшения температуры застывания сложных эфиров растительных масел (варианты)
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
MX352758B (es) Metodos mejorados para preparar escualeno.
WO2009137778A3 (en) Methods and compositions for genetically engineering clostridia species
NO20083023L (no) Fremgangsmate for generering av dendrittiske celler under anvendelse av senket temperatur
PT1941027E (pt) Métodos e meios para proliferação de células estaminais e subsequente geração e expansão de células progenitoras, bem como produção de células efectoras como produtos terapêuticos clínicos
NO20075032L (no) Fremgangsmate for fremstilling av silisium med hoy renhet
WO2009076655A3 (en) Synthetic enzymes derived from computational design
DK2010565T3 (da) Fremgangsmåde til produktion af rekombinant protein i CHO-celler
IN2012DN03844A (de)
EA201170477A1 (ru) СПОСОБ СИНТЕЗА (Aib)hGLP-1(7-36)-NH
MX2021013223A (es) Celulas que expresan un receptor quimerico de un locus cd247 modificado, polinucleotidos relacionados y metodos.
DK1794302T3 (da) Fremgangsmåde til at forøge frøvægt
MX2009007823A (es) Colorantes dispersos, su preparacion y su uso.
EA200800107A1 (ru) Способ получения липида из клеток
WO2008060792A3 (en) Novel cells, compositions, and methods
DK1594970T3 (da) Fremgangsmåde til generering af rekombinant MVA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application